PROCALCITONIN-AIDED ANTIBIOTIC THERAPY MANAGEMENT IN HOSPITAL-ACQUIRED PNEUMONIA AND HEALTHCARE-ASSOCIATED PNEUMONIA: A RANDOMISED CONTROLLED TRIAL (THE PROHAP STUDY)

被引：0
|
作者：
Beni, I. [1 ]
Fauzi, M. [1 ]
Norzailin, A. [1 ]
Shamsul, A. [1 ]
Aini, U. Nor [1 ]
Roslina, A. [1 ]
机构：
[1] Univ Kebangsaan Malaysia, Med Ctr, Kuala Lumpur, Malaysia
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: A multicenter retrospective cohort study
    Komiya, Kosaku
    Ishii, Hiroshi
    Umeki, Kenji
    Mizunoe, Shunji
    Okada, Fumito
    Johkoh, Takeshi
    Kadota, Jun-ichi
    RESPIROLOGY, 2013, 18 (03) : 514 - 521
  • [42] Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia
    Madaras-Kelly, Karl J.
    Remington, Richard E.
    Fan, Vincent S.
    Sloan, Kevin L.
    JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (03) : 195 - 202
  • [43] Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia
    Tan, Ying Xian
    Wong, Gah Wai
    Tan, Ying Huan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1555 - 1562
  • [44] Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia
    Ying Xian Tan
    Gah Wai Wong
    Ying Huan Tan
    International Journal of Clinical Pharmacy, 2021, 43 : 1555 - 1562
  • [45] Utility of procalcitonin in predicting mortality among cases of hospital-acquired pneumonia: a North Indian study
    Kumar, Sandeep
    Jan, Rafi A.
    Rasool, Roohi
    Fomda, Bashir A.
    Koul, Parvaiz A.
    Shah, Sonaullah
    Hafiz, Umar
    Qadri, Syed M.
    Masoodi, Shariq R.
    Muzamil, Mudasir
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2018, 67 (02): : 126 - 135
  • [46] Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia
    Simonetti, A.
    Viasus, D.
    Garcia-Vidal, C.
    Adamuz, J.
    Roset, A.
    Manresa, F.
    Dorca, J.
    Gudiol, F.
    Carratala, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (11) : 1149 - 1155
  • [47] Cohort study of patients with advanced cancer: outcomes associated with duration of antibiotic therapy for non-ventilator hospital-acquired pneumonia
    Lee, Seohyuk
    Benson, Jemma
    Cohen, Avi
    Quagliarello, Vincent
    Juthani-Mehta, Manisha
    Datta, Rupak
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
  • [48] Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial
    Hugh Wright
    Patrick N. A. Harris
    Mark D. Chatfield
    David Lye
    Andrew Henderson
    Tiffany Harris-Brown
    Anna Donaldson
    David L. Paterson
    Trials, 22
  • [49] Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial
    Wright, Hugh
    Harris, Patrick N. A.
    Chatfield, Mark D.
    Lye, David
    Henderson, Andrew
    Harris-Brown, Tiffany
    Donaldson, Anna
    Paterson, David L.
    TRIALS, 2021, 22 (01)
  • [50] Pharmacokinetic/Pharmacodynamics-Optimized Antimicrobial Therapy in Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia
    Sulaiman, Helmi
    Abdul-Aziz, Mohd H.
    Roberts, Jason A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (03) : 271 - 286
12345